Glaxosmithkline Pharmaceuticals reports consolidated net loss of Rs 661 crore in Q3

04 Feb 2020 Evaluate

Glaxosmithkline Pharmaceuticals has reported results for third quarter ended December 31, 2019.

The company has reported a net loss of Rs 644.14 crore for the quarter under review against net profit of Rs 112.97 crore for the same quarter in the previous year. Total income of the company decreased by 5.56% at Rs 794.93 crore for Q3FY20 as compared Rs 841.77 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a net loss of Rs 661.16 crore for the quarter under review against net profit of  Rs 113.67 crore for the same quarter in the previous year. Total income of the company decreased by 5.56% at Rs 795.09 crore for Q3FY20 as compared Rs 841.93 crore for the corresponding quarter previous year.

Glaxosmithkline Phar Share Price

2484.70 -13.65 (-0.55%)
24-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1737.50
Dr. Reddys Lab 1266.35
Cipla 1496.35
Zydus Lifesciences 917.45
Lupin 2109.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×